NASDAQ Newsroom NASDAQ Investor Relations Listed Companies How our Market Works NASDAQ Corporate www.NASDAQ.com
Nasdaq
Web NASDAQ.com   

deCODE genetics, Inc. [DCGN] President, Chairman & CEO Rings The NASDAQ Stock Market Opening Bell
 

deCODE genetics, Inc. [DCGN] President, Chairman & CEO Rings The NASDAQ Stock Market Opening Bell

Dr. Kari Stefansson, President, Chairman & CEO of deCODE genetics, Inc. (NASDAQ: DCGN),
Rings The NASDAQ Stock Market Opening Bell

Wednesday, July 20, 2005
at NASDAQ's MarketSite
in New York City.



deCODE genetics, Inc.

 
Additional Photographs & Reprint Permissions |
Archived MarketSite Events | Summary Quote

Dr. Kari Stefansson, President, Chairman & CEO of deCODE genetics, Inc. (NASDAQ: DCGN), presides over the opening bell to celebrate deCODE's 5 year anniversary on NASDAQ. deCODE is a biopharmaceutical company developing of drugs for common using its discoveries in human genetics.

deCODE is a global leader in gene discovery -- its population approach and resources have enabled the company to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing drug targets rooted in the basic biology of disease. The company currently has compounds in clinical development for heart attack, peripheral artery disease and asthma, and is broadening its pipeline through gene and target discovery work in 50 of the most common diseases.




Reprints

Click for larger pictures of the NASDAQ MarketSite.

Additional Photographs for 07/20/2005

© Copyright 2005, The NASDAQ Stock Market, Inc.
Reprinted with the permission of The Nasdaq Stock Market, Inc.